Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125735252 | 12573525 | 2 | F | 20160921 | 20160720 | 20160926 | PER | US-PFIZER INC-2016316572 | PFIZER | 65.00 | YR | F | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125735252 | 12573525 | 1 | PS | IBRANCE | PALBOCICLIB | 1 | 125 MG, UNK | U | 207103 | 125 | MG | CAPSULE | |||||||
| 125735252 | 12573525 | 2 | SS | FEMARA | LETROZOLE | 1 | UNK | U | 0 | ||||||||||
| 125735252 | 12573525 | 3 | SS | LETROZOLE. | LETROZOLE | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125735252 | 12573525 | Depression | |
| 125735252 | 12573525 | Dry skin | |
| 125735252 | 12573525 | Fatigue | |
| 125735252 | 12573525 | Lung disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125735252 | 12573525 | 1 | 20160311 | 0 |